Search results for: “Crispr”
-
Crispr Heart Disease Biotech Raises $94M in New Funds
A company applying Crispr gene-editing technology to treat inherited heart disease is raising $94 million in its second venture funding round.
-
Gates Funding Home-Based Crispr Covid-19 Diagnostic
A medical device developer is receiving a Gates Foundation grant for a simple test to detect Covid-19 infections, done completely at home.
-
Crispr Edits Out HIV-Like Genes from Monkey DNA
Researchers show the gene-editing technique Crispr can remove genes gained from infections similar to HIV in lab monkeys, as well as viral signals from their bodies.
-
Biotech Creating More Efficient Crispr Therapies
A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins.
-
Nanoscale Particles Deliver Crispr Cancer Treatments
Researchers in Israel developed techniques to deliver gene editing therapies with lipid nanoscale particles that in lab mice killed cancer cells and increased survival.
-
Electric Crispr Chip Quickly Detects Covid-19 Virus
An engineering lab developed a chip device that uses gene editing and an electric field to detect viruses responsible for Covid-19 infections.
-
Crispr Therapy Shown to Help Blood Disorder Patients
Interim clinical trial results show an experimental treatment derived from gene-edited stem cells relieves symptoms in patients with severe inherited blood diseases.
-
Quick Crispr-Based Test Detects Malaria in Blood
A blood test designed for low-resource field settings is shown to quickly detect and distinguish between different malaria parasites needed to accurately diagnose the disease.
-
Crispr Heart Therapy Demonstrated in Monkeys
An experimental therapy using a precise gene editing technique is shown in lab monkeys to reverse the cause of a chronic form of heart disease.
-
Biotechs Partner on Crispr for Stem Cell Transplants
A biotechnology partnership is evaluating a synthetic antibody to make it safer for people with genetic diseases to receive gene-edited bone marrow stem-cell transplants.